PHC3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.410600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.072200E-01
Normal-vs-Stage2
5.616200E-01
Normal-vs-Stage3
2.879600E-01
Normal-vs-Stage4
9.618400E-01
Stage1-vs-Stage2
8.200800E-01
Stage1-vs-Stage3
1.258280E-02
Stage1-vs-Stage4
2.934200E-01
Stage2-vs-Stage3
6.600700E-04
Stage2-vs-Stage4
1.236780E-01
Stage3-vs-Stage4
8.897900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.394800E-01
Normal-vs-AfricanAmerican
4.938800E-01
Normal-vs-Asian
1.743210E-01
Caucasian-vs-AfricanAmerican
6.539400E-01
Caucasian-vs-Asian
4.281200E-01
AfricanAmerican-vs-Asian
3.889400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.351600E-01
Normal-vs-Female
5.510800E-01
Male-vs-Female
7.941200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.181800E-01
Normal-vs-Age(41-60Yrs)
6.887200E-01
Normal-vs-Age(61-80Yrs)
4.937200E-01
Normal-vs-Age(81-100Yrs)
4.081600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.233600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.137800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.236600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.382600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.562000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.466800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.938600E-01
Normal-vs-Daily Drinker
4.162000E-01
Normal-vs-Weekly Drinker
4.542600E-01
Normal-vs-Occasional Drinker
3.439400E-01
Normal-vs-Social Drinker
4.222200E-01
Non Drinker-vs-Daily Drinker
3.630200E-01
Non Drinker-vs-Weekly Drinker
6.936800E-01
Non Drinker-vs-Occasional Drinker
3.571600E-01
Non Drinker-vs-Social Drinker
2.262800E-01
Daily Drinker-vs-Weekly Drinker
7.082400E-01
Daily Drinker-vs-Occasional Drinker
8.504500E-02
Daily Drinker-vs-Social Drinker
4.251600E-02
Weekly Drinker-vs-Occasional Drinker
2.700000E-01
Weekly Drinker-vs-Social Drinker
1.734580E-01
Occasional Drinker-vs-Social Drinker
7.782200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.926000E-02
Normal-vs-Grade 2
6.215400E-03
Normal-vs-Grade 3
1.916200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.399800E-02
Grade 1-vs-Grade 3
1.638190E-02
Grade 1-vs-Grade 4
7.926000E-02
Grade 2-vs-Grade 3
2.094400E-01
Grade 2-vs-Grade 4
6.215400E-03
Grade 3-vs-Grade 4
1.916200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.700000E-01
Normal-vs-NonDiabetic
5.215800E-01
Diabetic-vs-NonDiabetic
4.168400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.190800E-01
Normal-vs-NoPancreatitis
5.162000E-01
Pancreatitis-vs-NoPancreatitis
9.945200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.031400E-01
Normal-vs-N1
5.645000E-01
N0-vs-N1
3.395800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.936800E-01
Normal-vs-TP53-NonMutant
6.125000E-01
TP53-Mutant-vs-TP53-NonMutant
3.942400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
